Peter A. Thompson, Director at ARS Pharmaceuticals, Inc. (SPRY), sold 83,695 shares at $13.00 ($1.1M) on 2024-08-26, disclosed to the SEC on 2024-08-28.
Open-market sale of $1.1M SPRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SION | SELL | 2026-05-29 | $4K | — | Filing → |
| SION | SELL | 2026-05-11 | $13.4M | — | Filing → |
| SION | SELL | 2026-04-21 | $2.5M | — | Filing → |